Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |